Product NDC: | 60505-3280 |
Proprietary Name: | levetiracetam extended-release |
Non Proprietary Name: | levetiracetam |
Active Ingredient(s): | 500 mg/1 & nbsp; levetiracetam |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-3280 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091261 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110912 |
Package NDC: | 60505-3280-5 |
Package Description: | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-3280-5) |
NDC Code | 60505-3280-5 |
Proprietary Name | levetiracetam extended-release |
Package Description | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (60505-3280-5) |
Product NDC | 60505-3280 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levetiracetam |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20110912 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | LEVETIRACETAM |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |